
HeartBeam to Showcase FDA-Cleared Cardiac Technology at JP Morgan Healthcare Conference
HeartBeam's participation in the JP Morgan 2026 Annual Healthcare Conference highlights the importance of its FDA-cleared cable-free 12-lead ECG synthesis technology for arrhythmia assessment, which could transform remote cardiac monitoring and patient care outside traditional medical facilities.
Read full story






















